BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 16998505)

  • 1. ATM and breast cancer susceptibility.
    Ahmed M; Rahman N
    Oncogene; 2006 Sep; 25(43):5906-11. PubMed ID: 16998505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ataxia-telangiectasia mutated gene and breast cancer susceptibility].
    Zhang N; Che J; Bai S; Wu Z; Cui Y; Zou W
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):9-15. PubMed ID: 20353086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of mutations in ATM to breast cancer development in the Czech population.
    Soukupova J; Dundr P; Kleibl Z; Pohlreich P
    Oncol Rep; 2008 Jun; 19(6):1505-10. PubMed ID: 18497957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATM gene and ataxia telangiectasia.
    Mavrou A; Tsangaris GT; Roma E; Kolialexi A
    Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
    Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
    Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization connects individual patient mutations in ataxia telangiectasia mutated (ATM) with dysfunction of specific DNA double-strand break-repair signaling pathways.
    Keimling M; Volcic M; Csernok A; Wieland B; Dörk T; Wiesmüller L
    FASEB J; 2011 Nov; 25(11):3849-60. PubMed ID: 21778326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
    Lu S; Shen K; Wang Y; Santner SJ; Chen J; Brooks SC; Wang YA
    Carcinogenesis; 2006 Apr; 27(4):848-55. PubMed ID: 16400190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry.
    Graña B; Fachal L; Darder E; Balmaña J; Ramón Y Cajal T; Blanco I; Torres A; Lázaro C; Diez O; Alonso C; Santamariña M; Velasco A; Teulé A; Lasa A; Blanco A; Izquierdo A; Borràs J; Gutiérrez-Enríquez S; Vega A; Brunet J
    Breast Cancer Res Treat; 2011 Jul; 128(2):573-9. PubMed ID: 21445571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
    Pylkäs K; Tommiska J; Syrjäkoski K; Kere J; Gatei M; Waddell N; Allinen M; Karppinen SM; Rapakko K; Kääriäinen H; Aittomäki K; Blomqvist C; Mustonen A; Holli K; Khanna KK; Kallioniemi OP; Nevanlinna H; Winqvist R
    Carcinogenesis; 2007 May; 28(5):1040-5. PubMed ID: 17166884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nonsense mutation (E1978X) in the ATM gene is associated with breast cancer.
    Bogdanova N; Cybulski C; Bermisheva M; Datsyuk I; Yamini P; Hillemanns P; Antonenkova NN; Khusnutdinova E; Lubinski J; Dörk T
    Breast Cancer Res Treat; 2009 Nov; 118(1):207-11. PubMed ID: 18807267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
    Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
    Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations.
    Brunet J; Gutiérrez-Enríquez S; Torres A; Bérez V; Sanjosé S; Galceran J; Izquierdo A; Menéndez JA; Gumà J; Borràs J
    Clin Genet; 2008 May; 73(5):465-73. PubMed ID: 18384426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two ATM variants and breast cancer risk.
    Thompson D; Antoniou AC; Jenkins M; Marsh A; Chen X; Wayne T; Tesoriero A; Milne R; Spurdle A; Thorstenson Y; Southey M; Giles GG; Khanna KK; Sambrook J; Oefner P; Goldgar D; Hopper JL; Easton D; Chenevix-Trench G;
    Hum Mutat; 2005 Jun; 25(6):594-5. PubMed ID: 15880680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL; Murali R; Bilous AM; Farshid G; Waring P; Provan P; Byth K; Thorne H; ; Kirk JA
    Histopathology; 2006 Nov; 49(5):523-32. PubMed ID: 17064299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants.
    Hall J
    Cancer Lett; 2005 Sep; 227(2):105-14. PubMed ID: 16112413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ATM in breast cancer development.
    Prokopcova J; Kleibl Z; Banwell CM; Pohlreich P
    Breast Cancer Res Treat; 2007 Aug; 104(2):121-8. PubMed ID: 17061036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females.
    Wang HC; Chang WS; Tsai RY; Tsai CW; Liu LC; Su CH; Cheng HN; Tsou YA; Sun SS; Lin CC; Bau DT
    Anticancer Res; 2010 Dec; 30(12):5217-21. PubMed ID: 21187516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cancer by ATM missense mutations in the general population.
    Dombernowsky SL; Weischer M; Allin KH; Bojesen SE; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Oncol; 2008 Jun; 26(18):3057-62. PubMed ID: 18565893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity].
    Chargari C; Kirova YM; Even C; Monnier L; Dendale R; Campana F; Fourquet A
    Cancer Radiother; 2009 Jun; 13(3):164-72. PubMed ID: 19162519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients.
    Dörk T; Bendix R; Bremer M; Rades D; Klöpper K; Nicke M; Skawran B; Hector A; Yamini P; Steinmann D; Weise S; Stuhrmann M; Karstens JH
    Cancer Res; 2001 Oct; 61(20):7608-15. PubMed ID: 11606401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.